• Citer

Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.

par Eckle, Tobias;Krahn, Thomas;Grenz, Almut;Köhler, David;Mittelbronn, Michel;Ledent, Catherine ;Jacobson, Marlene A;Osswald, Hartmut;Thompson, Linda F;Unertl, Klaus;Eltzschig, Holger K
Référence Circulation, 115, 12, page (1581-1590)
Publication Publié, 2007-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.
Auteur:	Eckle, Tobias; Krahn, Thomas; Grenz, Almut; Köhler, David; Mittelbronn, Michel; Ledent, Catherine; Jacobson, Marlene A; Osswald, Hartmut; Thompson, Linda F; Unertl, Klaus; Eltzschig, Holger K
Informations sur la publication:	Circulation, 115, 12, page (1581-1590)
Statut de publication:	Publié, 2007-03
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Adenosine
	Infarction
	Ischemia
	Nucleotidase
	Reperfusion
MeSH keywords:	5'-Nucleotidase -- deficiency
	5'-Nucleotidase -- genetics
	5'-Nucleotidase -- physiology
	Adenosine -- physiology
	Aminopyridines -- pharmacology
	Aminopyridines -- therapeutic use
	Animals
	Cardiotonic Agents -- pharmacology
	Cardiotonic Agents -- therapeutic use
	Cell Hypoxia -- genetics
	Drug Evaluation, Preclinical
	Extracellular Fluid -- metabolism
	Female
	Ischemic Preconditioning, Myocardial
	Male
	Mice
	Mice, Inbred C57BL
	Mice, Knockout
	Myocardial Infarction -- pathology
	Myocardial Ischemia -- drug therapy
	Myocardial Ischemia -- metabolism
	Neutrophils
	Receptor, Adenosine A2B -- biosynthesis
	Receptor, Adenosine A2B -- deficiency
	Receptor, Adenosine A2B -- drug effects
	Receptor, Adenosine A2B -- genetics
	Receptor, Adenosine A2B -- physiology
	Up-Regulation
	Xanthines -- pharmacology
	Xanthines -- toxicity
Note générale:	Journal Article
	Research Support, N.I.H., Extramural
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0009-7322
	info:doi/10.1161/CIRCULATIONAHA.106.669697
	info:pii/CIRCULATIONAHA.106.669697
	info:scp/34247343418
	info:pmid/17353435